COGNOS THERAPEUTICS
Cognos Therapeutics is a medical device company that develops diagnostic and drug delivery devices designed to detect diseases and deliver drugs. The company's devices radically advance the diagnosis and treatment of neuropathic diseases including tumor-based brain and spinal cancers, degenerative cognition disorders, cerebral trauma occurrences, and other Central Nervous System afflictions that enable doctors to detect diseases, monitor their patients, and deliver medicines as per requirements. Cognos Therapeutics was established in 2003 and is headquartered in Inglewood, California.
COGNOS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2003-01-01
Address:
Inglewood, California, United States
Country:
United States
Website Url:
http://www.cognosthx.com
Total Employee:
1+
Status:
Active
Contact:
310-641-2700
Email Addresses:
[email protected]
Total Funding:
3.87 M USD
Technology used in webpage:
Microsoft Exchange Online Google Maps Google Maps API
Current Employees Featured
Founder
Official Site Inspections
http://www.cognosthx.com
- Host name: 123.217.117.34.bc.googleusercontent.com
- IP address: 34.117.217.123
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cognos Therapeutics"
Cognos Therapeutics, Inc. | About Cognos
Cognos Therapeutics is a high technology medical technology company specializing in innovative drug delivery solutions. Our flagship product, SINNAIS™, is a fully implantable drug delivery pump that features an AI …See details»
Cognos Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 310-641-2700 Cognos Therapeutics is a medical device company that develops diagnostic and drug …See details»
Cognos Therapeutics Inc | LinkedIn
Cognos Therapeutics Inc. (Cognos) is an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases …See details»
Cognos Therapeutics - PitchBook
Www.cognosthx.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 6053 West Century Boulevard; Suite 1000; Los Angeles, …See details»
Recommended Stories
Jan 3, 2023 Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) ("Nocturne"), a publicly-traded special purpose acquisition company, today announced execution of a …See details»
Company Information - RocketReach
Cognos Therapeutics Inc. (Cognos) is an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases …See details»
Cognos Therapeutics, Inc. | Home
A Novel and Ground-Breaking Advancement. SINNAIS™ Implantable Smart Pump. Our innovative SINNAIS™ implantable pump represents a platform designed for the future, utilizing …See details»
Cognos Therapeutics - Overview, News & Similar companies
Jun 1, 2021 Who is Cognos Therapeutics. Cognos Therapeutics Inc. (Cognos) is an advanced medical device company focused on creating unique technologies to radically advance the …See details»
Cognos Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jun 30, 2023 Explore Cognos Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Cognos Therapeutics Announces Formation of Industry Advisory …
Aug 6, 2024 Mark Webster Appointed Co-Chair of Advisory BoardINGLEWOOD, CA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cognos Therapeutics (“Cognos” and “the Company”), a leading …See details»
Cognos Therapeutics, Inc. | Investor Relations Overview
[email protected]. Investor Relations. Gilmartin Group San Francisco 60 E Sir Francis Drake Blvd, Suite 208 Larkspur, CA 94939 [email protected]. Transfer Agent. Continental Stock …See details»
Cognos Therapeutics Corp. Engages Maxim Group LLC for
INGLEWOOD, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Cognos Therapeutics Corp. (“Cognos”, the Company”), an advanced medical device...See details»
Cognos Therapeutics, Inc. | Corporate Governance
Board Diversity Matrix as of January 25, 2024; Total Number of Directors: Gender Identity Female Male Non-binary Did not disclose gender; Directors # # # # Demographic BackgroundSee details»
Cognos Therapeutics Corp. Engages Maxim Group LLC for …
INGLEWOOD, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Cognos Therapeutics Corp. (“Cognos”, the Company”), an advanced medical device company focused …See details»
Cognos Therapeutics, Inc. | Investor Resources
[email protected]. Investor Relations. Gilmartin Group San Francisco 60 E Sir Francis Drake Blvd, Suite 208 Larkspur, CA 94939 [email protected]. Transfer Agent. Continental Stock …See details»
Organization visualization - IBM
Organization visualizations are supported as of IBM® Cognos® Analytics with Watson 11.1.7 Note: This example was created for advanced custom visualization developers. It is a code …See details»
Cognos Therapeutics | VentureRadar
Cognos Therapeutics Inc. (Cognos) is an advanced medical device company focused on creating unique technologies to radically advance the diagnosis... ... Find out ...See details»
Cognos Announces U.S. Patent Award for Cerebral Microdialysis
Nov 6, 2023 According to a 2023 GlobalData analysis, the global market for Alzheimer’s disease is projected to grow at a compound annual rate of 20.0% from $2.2 billion in 2020 to $13.7 …See details»
Cognos Therapeutics, Inc. | Dr. Winston Wu, PhD
Dr. Winston Wu has served as the Senior Vice President of Product Development and Chief Technology Officer of Cognos since July 2017. At UCLA, his work in creating one of the first …See details»
Cognos Therapeutics, Inc. | Christopher Smith
From 1992 to 2022, he served in various roles, holding progressively more responsible roles within the BDO organization concluding with Global Head of Accounting and Auditing. During …See details»